Data di Pubblicazione:
2019
Abstract:
Defects in the homologous recombination (HR) repair pathway are of clinical interest due to sensitivity of HR-deficient cells to PARP inhibitors. We were interested in defining PARP vulnerability in patients with metastatic colorectal cancer (mCRC) carrying KRAS and BRAF mutations who display poor prognosis, have limited therapeutic options, and represent an unmet clinical need.
Tipologia CRIS:
03A-Articolo su Rivista
Elenco autori:
Arena, Sabrina; Corti, Giorgio; Durinikova, Erika; Montone, Monica; Reilly, Nicole M; Russo, Mariangela; Lorenzato, Annalisa; Arcella, Pamela; Lazzari, Luca; Rospo, Giuseppe; Pagani, Massimiliano; Cancelliere, Carlotta; Negrino, Carola; Isella, Claudio; Bartolini, Alice; Cassingena, Andrea; Amatu, Alessio; Mauri, Gianluca; Sartore-Bianchi, Andrea; Mittica, Gloria; Medico, Enzo; Marsoni, Silvia; Linnebacher, Michael; Abrignani, Sergio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto
Link alla scheda completa:
Link al Full Text:
Pubblicato in: